https://www.selleckchem.com/pr....oducts/mk-8353-sch90
nium (mildronat) in patients with chronic CVD are demonstrated that makes it possible to recommend this drug for widespread use by specialists in clinical practice. To study non-motor conditions in people with diabetes in comparison with patients with cervicalgia. The study included 170 people. The main group consisted of 120 respondents with cervical dystonia (CD) aged 27 to 82 years. The diagnosis of CD was based on the Clinical guidelines for the diagnosis and treatment of dystonia adopted by the European Federation of Neur
Respect!
Kommentar
Delen
